Camp4 Therapeutics Corporation
CAMP
$2.05
$0.063.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -2.22% | -15.30% | -1.72% | -1.72% | |
| Total Depreciation and Amortization | -3.91% | -2.79% | 5.78% | 5.78% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 17.71% | 83.20% | 0.36% | 0.36% | |
| Change in Net Operating Assets | 195.19% | -63.41% | 35.29% | 35.29% | |
| Cash from Operations | 4.20% | -47.89% | 4.79% | 4.79% | |
| Capital Expenditure | -8.23% | 100.00% | 21.93% | 21.93% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -8.23% | 100.00% | 21.93% | 21.93% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 10.59% | -0.49% | -172.00% | -172.00% | |
| Issuance of Common Stock | 44,080.92% | 3,000.00% | -81.82% | -81.82% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 116,071.43% | -90.15% | -278.84% | -278.84% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 608.82% | -44.73% | -1.15% | -1.15% | |